IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,510.50
Bid: 1,511.00
Ask: 1,511.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.033%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,510.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks flat on euro uncertainty

Tue, 12th Jun 2012 08:40

- Markets still digesting Spanish request for aid- Investors look ahead to Greek elections, Italian bond auction- Miners and banks drop early onLondon's blue-chip index opened flat on Tuesday morning with all eyes on the Eurozone following the recent Spanish request for aid and ahead of the crucial Greek elections at the weekend.Stocks opened strongly yesterday after Spain requested a credit line of up to €100bn to help recapitalise its banks, but gains were quickly pared as the markets digested what this would mean in the longer term."There is still the Greece election this coming weekend and beyond this no shortage of concerns and areas of vulnerability throughout the Eurozone. This crisis will rumble on," said RBS's chief economist Andrew McLaughlin yesterday.Italy also remains a worry for investors as the country's benchmark bond yields tracked Spanish rates higher yesterday ahead of a bond auction later this week.International Monetary Fund (IMF) Managing Director Christine Lagarde has denied that there is a three-month make-or-break deadline for the euro despite billionaire investor George Soros's prediction last week that the Eurozone had only that much time to fix its problems.Meanwhile, European Commission (EC) President José Manuel Barroso has called on EU leaders to take a "big step" and agree on a banking union to be implemented as early as next year. FTSE 100: Miners, banks hit by risk aversionMining stocks were out of favour as investors shied away from risk on the back of the Eurozone uncertainty: Evraz, Kazakhmys, ENRC and Antofagasta were registering moderate falls in the opening hour, as too were potential merger partners Glencore and Xstrata. In a research note this morning, Jefferies said that certain factors have reduced the pressure on Glencore to bump up its offer for Xstrata shareholders and said that the ratio of 2.8 Glencore shares per Xstrata share is now expected to succeed.Banks were also under some selling pressure early on with Barclays RBS and Lloyds among the worst performers. Lloyds is taking the first step to getting out of Japan after announcing the sale of its remittance business in the country. The group, which is 43% owned by the UK taxpayer, is selling GoLloyds to Shinsei Bank.Supermarket firm Sainsbury was on the up after making a surprise move into the e-book retail market with the acquisition of HMV's stake in online venture Anobii. Pharmaceuticals giant GlaxoSmithKline edged higher after signing an agreement to buy eczema treatment drug 'Toctino' from Basilea Pharmaceutica for an initial payment of £146m in cash.FTSE 250: RPC, Spirit drop after resultsPlastic packaging firm RPC Group slumped despite hiking its dividend after the successful acquisition of food packaging firm Superfos helped drive up profits in the year to the end of March.Like-for-like sales growth slowed at Spirit as the pubs group ran into stronger comparatives from a year earlier, while things are getting worse in the group's leased estate, causing shares to fall early on.Insurance group Amlin was a high riser after Deutsche Bank upgraded its rating on the stock to buy and lifted its target price from 420p to 435p. Meanwhile, airline easyJet was under the weather after a HSBC downgrade to neutral.FTSE 100 - RisersICAP (IAP) 344.60p +2.16%British American Tobacco (BATS) 3,163.00p +1.67%Admiral Group (ADM) 1,091.00p +1.49%Unilever (ULVR) 2,063.00p +1.23%Schroders (Non-Voting) (SDRC) 995.00p +1.22%Serco Group (SRP) 551.00p +0.92%Vodafone Group (VOD) 172.60p +0.91%Schroders (SDR) 1,257.00p +0.88%Imperial Tobacco Group (IMT) 2,399.00p +0.88%Severn Trent (SVT) 1,804.00p +0.84%FTSE 100 - FallersEvraz (EVR) 264.90p -2.82%Barclays (BARC) 185.80p -2.49%ARM Holdings (ARM) 494.40p -2.20%Royal Bank of Scotland Group (RBS) 216.70p -2.12%Petrofac Ltd. (PFC) 1,505.00p -1.76%ITV (ITV) 71.15p -1.52%Kazakhmys (KAZ) 682.50p -1.44%Eurasian Natural Resources Corp. (ENRC) 401.00p -1.43%Man Group (EMG) 75.65p -1.37%Weir Group (WEIR) 1,430.00p -1.31%FTSE 250 - RisersNorthgate (NTG) 173.10p +4.91%Centamin (DI) (CEY) 70.05p +4.40%Amlin (AML) 335.60p +3.74%Ruspetro (RPO) 153.00p +3.73%Rank Group (RNK) 121.10p +3.50%IG Group Holdings (IGG) 456.20p +1.92%New World Resources A Shares (NWR) 312.10p +1.89%Big Yellow Group (BYG) 282.60p +1.51%Petra Diamonds Ltd.(DI) (PDL) 128.80p +1.34%Cape (CIU) 266.10p +1.29%FTSE 250 - FallersRPC Group (RPC) 370.10p -6.78%Bumi (BUMI) 351.00p -3.84%Spirit Pub Company (SPRT) 46.00p -3.66%easyJet (EZJ) 486.20p -2.74%Talvivaara Mining Company (TALV) 143.40p -2.45%Redrow (RDW) 111.00p -2.37%Fenner (FENR) 357.30p -2.32%Aquarius Platinum Ltd. (AQP) 64.00p -2.29%Regus (RGU) 87.70p -2.23%Savills (SVS) 319.60p -2.17%BC
More News
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.